These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Haemophagocytosis in bone marrow aspirates in patients with COVID-19. Debliquis A; Harzallah I; Mootien JY; Poidevin A; Labro G; Mejri A; Lamarque M; Kuteifan K; Drénou B Br J Haematol; 2020 Jul; 190(2):e70-e73. PubMed ID: 32529634 [No Abstract] [Full Text] [Related]
28. Interleukin-1 blockade with anakinra in acute leukaemia patients with severe COVID-19 pneumonia appears safe and may result in clinical improvement. Day JW; Fox TA; Halsey R; Carpenter B; Kottaridis PD Br J Haematol; 2020 Jul; 190(2):e80-e83. PubMed ID: 32438450 [No Abstract] [Full Text] [Related]
29. Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin. Alunno A; Carubbi F; Rodríguez-Carrio J RMD Open; 2020 May; 6(1):. PubMed ID: 32423970 [TBL] [Abstract][Full Text] [Related]
30. Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children*. Rajasekaran S; Kruse K; Kovey K; Davis AT; Hassan NE; Ndika AN; Zuiderveen S; Birmingham J Pediatr Crit Care Med; 2014 Jun; 15(5):401-8. PubMed ID: 24583503 [TBL] [Abstract][Full Text] [Related]
31. Anakinra: a silver lining in COVID-19? Gupta R Crit Care; 2020 Oct; 24(1):598. PubMed ID: 33023646 [No Abstract] [Full Text] [Related]
32. Secondary HLH is uncommon in severe COVID-19. Wood H; Jones JR; Hui K; Mare T; Pirani T; Galloway J; Metaxa V; Benjamin R; Rutherford A; Cain S; Kulasekararaj AG Br J Haematol; 2020 Sep; 190(5):e283-e285. PubMed ID: 32526046 [No Abstract] [Full Text] [Related]
34. Cytokine release syndrome in severe COVID-19. Moore JB; June CH Science; 2020 May; 368(6490):473-474. PubMed ID: 32303591 [No Abstract] [Full Text] [Related]
35. Cytokine storm and use of anakinra in a patient with COVID-19. Nemchand P; Tahir H; Mediwake R; Lee J BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32933914 [TBL] [Abstract][Full Text] [Related]
36. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra). Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052 [TBL] [Abstract][Full Text] [Related]
37. An open label trial of anakinra to prevent respiratory failure in COVID-19. Kyriazopoulou E; Panagopoulos P; Metallidis S; Dalekos GN; Poulakou G; Gatselis N; Karakike E; Saridaki M; Loli G; Stefos A; Prasianaki D; Georgiadou S; Tsachouridou O; Petrakis V; Tsiakos K; Kosmidou M; Lygoura V; Dareioti M; Milionis H; Papanikolaou IC; Akinosoglou K; Myrodia DM; Gravvani A; Stamou A; Gkavogianni T; Katrini K; Marantos T; Trontzas IP; Syrigos K; Chatzis L; Chatzis S; Vechlidis N; Avgoustou C; Chalvatzis S; Kyprianou M; van der Meer JW; Eugen-Olsen J; Netea MG; Giamarellos-Bourboulis EJ Elife; 2021 Mar; 10():. PubMed ID: 33682678 [TBL] [Abstract][Full Text] [Related]
38. The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease. McGonagle D; Sharif K; O'Regan A; Bridgewood C Autoimmun Rev; 2020 Jun; 19(6):102537. PubMed ID: 32251717 [TBL] [Abstract][Full Text] [Related]
39. A plea for the pathogenic role of immune complexes in severe Covid-19. Vuitton DA; Vuitton L; Seillès E; Galanaud P Clin Immunol; 2020 Aug; 217():108493. PubMed ID: 32526273 [No Abstract] [Full Text] [Related]
40. Thromboinflammatory response in SARS-CoV-2 sepsis. Maiese A; Passaro G; Matteis A; Fazio V; Raffaele R; Paolo MD Med Leg J; 2020 Jul; 88(2):78-80. PubMed ID: 32490726 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]